Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has shared an update.
WuXi AppTec Co., Ltd. announced adjustments to the upper limit of the price for its A Share repurchase plans following the implementation of its 2024 Profit Distribution and 2025 Special Dividend Distribution. The company plans to repurchase A Shares through two separate plans in 2025, each with a budget of RMB1 billion, aiming to cancel and reduce registered capital. The adjustments in the share repurchase price limits are in response to the company’s dividend distributions, ensuring compliance with relevant regulations. This move is expected to impact the company’s capital structure and provide returns to shareholders.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company primarily focuses on providing comprehensive and integrated services for drug development and manufacturing.
Average Trading Volume: 9,275,315
Technical Sentiment Signal: Buy
Current Market Cap: HK$180.8B
Find detailed analytics on 2359 stock on TipRanks’ Stock Analysis page.